BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 6982774)

  • 21. [Tolerance and immunization trials with a commercial vaccine against Chlamydia psittaci and Coxiella burnetii].
    Döpfer G; Schmeer N; Frost JW; Lohrbach W; Wachendörfer G
    Dtsch Tierarztl Wochenschr; 1986 Jun; 93(6):267-9. PubMed ID: 3527655
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the immunogenicity of various phases of the Burneti rickettsia].
    Kudelina RI; Fedorova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1967 May; 44(5):17-21. PubMed ID: 5617968
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the reactivity and immunogenicity of a combined vaccine against abortion due to coxiellosis and chlamydiosis in sheep].
    Dravecký T; Kazár J; Zársky I; Schramek S; Urvölgyi J; Trávnicek M; Balascák J
    Vet Med (Praha); 1987 May; 32(5):309-13. PubMed ID: 3111068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reactogenic activity of C. burneti vaccines. II. Attempts to separate the protecting potency from the toxic and allergenic effects of phase I C. burneti vaccine].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):679-90. PubMed ID: 5742339
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs.
    Shapiro RA; Siskind V; Schofield FD; Stallman N; Worswick DA; Marmion BP
    Epidemiol Infect; 1990 Apr; 104(2):267-73. PubMed ID: 2182329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermal reactions and antibody responses in dairy cows and laboratory animals vaccinated with Coxiella burnetii.
    Biberstein EL; Crenshaw GL; Behymer DE; Franti CE; Bushnell RB; Riemann HP
    Cornell Vet; 1974 Jul; 64(3):387-406. PubMed ID: 4845729
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of lysozyme on the immune response of guinea pigs to the soluble phase 1 antigen of Coxiella burnetii.
    Wachter RF; Briggs GP
    Acta Virol; 1981 Jul; 25(4):241-4. PubMed ID: 6116419
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination of cattle workers at risk of Q fever on the north coast of New South Wales.
    Hutson B; Deaker RA; Newland J
    Aust Fam Physician; 2000 Jul; 29(7):708-9. PubMed ID: 10914459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Q fever vaccines: present status and application in man.
    Kazár J; Rehácek J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Nov; 267(1):74-8. PubMed ID: 3324573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunogenicity of an R. burneti strain isolated in Bulgaria].
    Pandŭrov S
    Vet Med Nauki; 1980; 17(1):90-4. PubMed ID: 7414937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological properties of the lipopolysaccharide-protein complex of Coxiella burnetii.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1978 Jul; 22(4):309-15. PubMed ID: 29470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
    Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ
    Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suitability of Coxiella burnetii strains for preparation of phase II artificial diagnostic antigen for microagglutination test.
    Urvölgyi J; Brezina R
    Acta Virol; 1979 Sep; 23(5):439-42. PubMed ID: 42306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.
    Ruble DL; Elliott JJ; Waag DM; Jaax GP
    Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of the immunogenicity of phase I antigen of Coxiella burnetii.
    Wachter RF; Briggs GP; Pedersen CE
    Infect Immun; 1978 Nov; 22(2):627-8. PubMed ID: 730378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Q fever in cows with special reference to Coxiella burnetii colonization of the udder].
    Moretti B
    Ann Ist Super Sanita; 1984; 20(4):317-27. PubMed ID: 6400460
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid immunofluorescent procedure for serodiagnosis of Q fever in mice, guinea pigs, sheep, and humans.
    Ascher MS; Horwith GS; Thornton MF; Greenwood JR; Berman MA
    Diagn Immunol; 1983; 1(1):33-8. PubMed ID: 6388964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.